Monthly Archives: January 2015

Home/2015/January

UK Pulls Stivarga From Cancer Drug Fund Endangering GIST Patients

The National Health Service (NHS) in the United Kingdom has announced plans to halt funding through the Cancer Drug Fund for regorafenib (Stivarga), thereby preventing GIST patients from having access to this life-saving medication.We at [...]

By |2018-09-10T09:36:55-04:00January 29th, 2015|Advocacy, News, Stivarga|

Protein Complex Believed To Be Cancer-Causing Gene

A recent study from MD Anderson provides insight into a protein complex that plays a significant role in cancer.In the study at the University of Texas MD Anderson Cancer center, similarities were drawn between bean [...]

By |2018-09-10T08:41:45-04:00January 6th, 2015|Drug Treatment, News, Research|

Clinical Registry Study Planned by ASCO

American Society of Clinical Oncology (ASCO) is planning its first-ever clinical registry study, the Targeted Agent and Profiling Utilization Registry (TAPUR).  ASCO plans should increase patient access to off-label drugs and match patients with [...]

By |2018-07-06T13:59:34-04:00January 6th, 2015|Gleevec, News, Patient Support, Side Effects, Stivarga, Sutent|

Fundacion GIST Advocates for Rare Disease Day In Mexico

LRG's Rodrigo Salas, member of the Board of Directors, was interviewed on Televisa Monterrey as part of Fundacion GIST Mexico's citizen initiative to have February 28 declared "Rare Disease Day" in their home state [...]

By |2018-09-10T08:46:14-04:00January 5th, 2015|Advocacy, Global, News|
Go to Top